These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32152480)

  • 1. NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium.
    Manuel Sánchez-Maldonado J; Martínez-Bueno M; Canhão H; Ter Horst R; Muñoz-Peña S; Moñiz-Díez A; Rodríguez-Ramos A; Escudero A; Sorensen SB; Hetland ML; Ferrer MA; Glintborg B; Filipescu I; Pérez-Pampin E; Conesa-Zamora P; García A; den Broeder A; De Vita S; Hove Jacobsen SE; Collantes E; Quartuccio L; Netea MG; Li Y; Fonseca JE; Jurado M; López-Nevot MÁ; Coenen MJH; Andersen V; Cáliz R; Sainz J
    Sci Rep; 2020 Mar; 10(1):4316. PubMed ID: 32152480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts.
    Sánchez-Maldonado JM; Cáliz R; López-Nevot MÁ; Cabrera-Serrano AJ; Moñiz-Díez A; Canhão H; Ter Horst R; Quartuccio L; Sorensen SB; Glintborg B; Hetland ML; Filipescu I; Pérez-Pampin E; Conesa-Zamora P; Swierkot J; den Broeder AA; De Vita S; Petersen ERB; Li Y; Ferrer MA; Escudero A; Netea MG; Coenen MJH; Andersen V; Fonseca JE; Jurado M; Bogunia-Kubik K; Collantes E; Sainz J
    Front Immunol; 2021; 12():672255. PubMed ID: 34777329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.
    Canet LM; Sánchez-Maldonado JM; Cáliz R; Rodríguez-Ramos A; Lupiañez CB; Canhão H; Martínez-Bueno M; Escudero A; Segura-Catena J; Sorensen SB; Hetland ML; Soto-Pino MJ; Ferrer MA; García A; Glintborg B; Filipescu I; Pérez-Pampin E; González-Utrilla A; Nevot MÁL; Conesa-Zamora P; Broeder AD; De Vita S; Jacobsen SEH; Collantes-Estevez E; Quartuccio L; Canzian F; Fonseca JE; Coenen MJH; Andersen V; Sainz J
    Pharmacogenomics J; 2019 Feb; 19(1):83-96. PubMed ID: 30287909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis.
    Ogawa Y; Takahashi N; Kaneko A; Hirano Y; Kanayama Y; Yabe Y; Oguchi T; Fujibayashi T; Takagi H; Hanabayashi M; Funahashi K; Hayashi M; Tsuboi S; Asai S; Asai N; Matsumoto T; Sobue Y; Ishiguro N; Kojima T
    Clin Rheumatol; 2019 Oct; 38(10):2757-2763. PubMed ID: 31179526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Immunochip-based interaction study of contrasting interaction effects with smoking in ACPA-positive versus ACPA-negative rheumatoid arthritis.
    Jiang X; Källberg H; Chen Z; Ärlestig L; Rantapää-Dahlqvist S; Davila S; Klareskog L; Padyukov L; Alfredsson L
    Rheumatology (Oxford); 2016 Jan; 55(1):149-55. PubMed ID: 26272072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of Fcgamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis.
    Thabet MM; Huizinga TW; Marques RB; Stoeken-Rijsbergen G; Bakker AM; Kurreeman FA; White SJ; Toes RE; van der Helm-van Mil AH
    Ann Rheum Dis; 2009 Nov; 68(11):1775-80. PubMed ID: 19019892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-C alleles confer risk for anti-citrullinated peptide antibody-positive rheumatoid arthritis independent of HLA-DRB1 alleles.
    Nordang GB; Flåm ST; Maehlen MT; Kvien TK; Viken MK; Lie BA
    Rheumatology (Oxford); 2013 Nov; 52(11):1973-82. PubMed ID: 23901134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A replication study confirms the association of dendritic cell immunoreceptor (DCIR) polymorphisms with ACPA - negative RA in a large Asian cohort.
    Guo J; Wu X; Too CL; Yin F; Lu X; He J; Li R; Liu X; Murad S; Padyukov L; Li Z
    PLoS One; 2012; 7(7):e41228. PubMed ID: 22829930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.
    Jiang X; Trouw LA; van Wesemael TJ; Shi J; Bengtsson C; Källberg H; Malmström V; Israelsson L; Hreggvidsdottir H; Verduijn W; Klareskog L; Alfredsson L; Huizinga TW; Toes RE; Lundberg K; van der Woude D
    Ann Rheum Dis; 2014 Oct; 73(10):1761-8. PubMed ID: 24812286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic approach demonstrates enrichment of multiple interactions between non-
    Diaz-Gallo LM; Ramsköld D; Shchetynsky K; Folkersen L; Chemin K; Brynedal B; Uebe S; Okada Y; Alfredsson L; Klareskog L; Padyukov L
    Ann Rheum Dis; 2018 Oct; 77(10):1454-1462. PubMed ID: 29967194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking and susceptibility to rheumatoid arthritis in a Swedish population-based case-control study.
    Hedström AK; Stawiarz L; Klareskog L; Alfredsson L
    Eur J Epidemiol; 2018 Apr; 33(4):415-423. PubMed ID: 29387991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of neuropeptide S receptor gene (NPSR1) polymorphism in rheumatoid arthritis.
    D'Amato M; Zucchelli M; Seddighzadeh M; Anedda F; Lindblad S; Kere J; Alfredsson L; Klareskog L; Padyukov L
    PLoS One; 2010 Feb; 5(2):e9315. PubMed ID: 20179762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients.
    Feitsma AL; Toes RE; Begovich AB; Chokkalingam AP; de Vries RR; Huizinga TW; van der Helm-van Mil AH
    Rheumatology (Oxford); 2007 Jul; 46(7):1092-5. PubMed ID: 17341507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis.
    Cantaert T; Brouard S; Thurlings RM; Pallier A; Salinas GF; Braud C; Klarenbeek PL; de Vries N; Zhang Y; Soulillou JP; Tak PP; Baeten D
    Arthritis Rheum; 2009 Jul; 60(7):1944-56. PubMed ID: 19565497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroxin substitution and the risk of developing rheumatoid arthritis; results from the Swedish population-based EIRA study.
    Bengtsson C; Padyukov L; Källberg H; Saevarsdottir S
    Ann Rheum Dis; 2014 Jun; 73(6):1096-100. PubMed ID: 23613482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic risk score composed of rheumatoid arthritis risk alleles, HLA-DRB1 haplotypes, and response to TNFi therapy - results from a Swedish cohort study.
    Jiang X; Askling J; Saevarsdottir S; Padyukov L; Alfredsson L; Viatte S; Frisell T
    Arthritis Res Ther; 2016 Dec; 18(1):288. PubMed ID: 27912794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis.
    Ciccacci C; Conigliaro P; Perricone C; Rufini S; Triggianese P; Politi C; Novelli G; Perricone R; Borgiani P
    Clin Exp Immunol; 2016 Nov; 186(2):157-163. PubMed ID: 27342690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology.
    Sherina N; Hreggvidsdottir HS; Bengtsson C; Hansson M; Israelsson L; Alfredsson L; Lundberg K
    Arthritis Res Ther; 2017 Sep; 19(1):219. PubMed ID: 28962582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
    Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of HLA-DRB1*13 alleles during specific phases in the development of ACPA-positive RA.
    van Heemst J; Hensvold AH; Jiang X; van Steenbergen H; Klareskog L; Huizinga TW; van der Helm-van Mil A; Catrina AI; Toes RE; Lundberg K; van der Woude D
    Ann Rheum Dis; 2016 Oct; 75(10):1891-8. PubMed ID: 26715653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.